molecules in vr: venetoclax, the first approved bcl-2 antagonist for chronic lymphocytic leukemia
Published 2 years ago • 260 plays • Length 11:35Download video MP4
Download video MP3
Similar videos
-
16:13
molecules in vr: investigating cyclin-dependent kinase selectivity
-
3:33
venetoclax (bcl 2 inhibitor)
-
1:48
explore our vitroids™ and lenticule® discs
-
2:29
(clonevo): cell cycle inhbition to target the evolution of urothelial cancer
-
4:38
venice i: venetoclax in r/r cll patients
-
8:18
the most beautiful pimple under a microscope!
-
41:13
microscopic world 12k ultra hd
-
5:31
the evolving role of liquid biopsy
-
2:08
the venice-1 trial: venetoclax monotherapy in r/r cll
-
0:13
ibidi - cells in focus: molecular processes in chemotactical polarized cells using lifeact-taggfp2
-
48:35
discovering cellular mechanisms and biomarkers in anti-pd1 non-responders..
-
0:54
veins reabsorb very little content from the extracellular fluid - with laura santambrogio, md, phd
-
15:57
gpcrs in vr: high-throughput virtual screening against 5-ht2a receptor with scientists from psylo
-
![plasma ceramides [a test in focus]](https://i.ytimg.com/vi/LNdmWGvOiUs/mqdefault.jpg)
5:04
plasma ceramides [a test in focus]
-
12:07
amazing microscopic world! common objects under the microscope || home experiments
-
1:38
polyomavirus nephritis | banff & beyond
-
5:58
the availability of multiple biosimilars for 1 biologic
-
3:13
venetoclax in rr cll
-
2:02
targeting the survival cascade of b-cells in lymphoid malignancies
-
3:12
immunotherapy animation - batu biologics’ vallovax™ technology
-
5:13
biologics
-
0:50
confocal microscopy | virtual lab